In diuretic renogram, what percentage is said that kidney drainage is functioning asnormally, obstructed
Reading File
Searching the Web
diuretic renogram drainage percentage normal obstructed criteria T1/2
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Here is a clear, complete answer based on authoritative textbook and guideline sources:
Diuretic Renogram: Drainage Interpretation Criteria
The key quantitative parameter used is the washout half-time (T½) - the time taken for 50% of the peak tracer activity to clear from the collecting system after furosemide administration.
Standard T½ Thresholds
| Category | T½ (minutes) | Interpretation |
|---|---|---|
| Normal | < 10 min | Good drainage, obstruction effectively excluded |
| Equivocal / Indeterminate | 10 - 20 min | Cannot reliably exclude or confirm obstruction |
| Obstructed | > 20 min | Significant obstruction likely |
Note: Bailey and Love's Surgery states T½ is "usually cleared within 10-15 minutes," with >20 minutes and differential function <40% on the affected side being suggestive of significant obstruction requiring surgical intervention.
The "50%" Figure You're Asking About
The percentage threshold most commonly cited is:
- >50% washout of tracer within 20 minutes after furosemide = normal / non-obstructed
- <50% tracer retained after the diuretic phase = suggests obstruction (especially if T½ >20 min)
This is used particularly with gravity-assisted drainage (GAD) - if >50% of residual activity remains after the patient stands upright for 5 minutes post-furosemide, true obstruction is confirmed (especially useful when T½ falls in the grey zone of 10-20 minutes).
Additional Context
- The SNMMI/EANM joint guideline notes that T½ should not be used as the sole criterion - the renogram curve shape (flat/rising curve after diuretic = obstruction), differential renal function, and clinical context must all be considered together.
- For Tc-99m MAG3 specifically, normal furosemide half-clearance is <9.8 minutes (Rossleigh et al.).
- A rising curve after furosemide injection strongly suggests obstruction regardless of the T½ value.
Sources: Bailey & Love's Short Practice of Surgery 28th Ed.; Campbell-Walsh-Wein Urology; SNMMI/EANM Guideline for Diuretic Renal Scintigraphy; StatPearls Nuclear Renal Scan.
Dtpa renogram, what is the percentage of drainage for indeterminate cases
Finding Sources
Searching the Web
DTPA diuretic renogram indeterminate drainage percentage criteria 50%
Finding Sources
Searching the Web
DTPA renogram "percentage drainage" indeterminate obstructed normal criteria classification
Reading Web Page
https://charles-metzger-yfm5.squarespace.com/s/Banks_RenalUp…
Finding Sources
Reading File
This is a very specific question about the percentage of drainage (not just T½) for indeterminate cases. Here is the complete, accurate answer:
DTPA Renogram: Percentage Drainage - Indeterminate Cases
The standard classification in diuretic renography uses T½ (washout half-time) as the primary criterion. There is no universally agreed single "percentage drainage" number that defines the indeterminate zone in the same way, but here is the full picture:
T½-Based Classification (Standard / Classic)
| Category | T½ | Meaning |
|---|---|---|
| Normal | < 10 minutes | Unobstructed |
| Indeterminate / Equivocal | 10 - 20 minutes | Cannot reliably confirm or exclude obstruction |
| Obstructed | > 20 minutes | Significant obstruction |
(Campbell-Walsh-Wein Urology; Bailey & Love's Surgery)
Percentage Drainage Thresholds
When expressed as a % of tracer remaining (or washed out) at 20 minutes after furosemide:
| Category | % Washout / Drainage |
|---|---|
| Normal | >50% washed out (i.e., <50% retained) |
| Indeterminate | ~50% retained - borderline, neither clearly washing out nor clearly static |
| Obstructed | >50% retained (with rising or plateau curve) |
The gravity-assisted drainage (GAD) refinement is particularly important for indeterminate cases: if >50% of residual activity remains after the patient stands upright for 5 minutes post-furosemide, true obstruction is confirmed. If it drains with gravity, obstruction is unlikely.
Additional Supporting Parameters for Indeterminate Cases
When T½ falls in the grey zone (10-20 min), these are evaluated together:
- 20-min to peak count ratio: Normal is ≤ 0.3 (30%); >30% is abnormal
- Curve shape: A rising or plateau curve after furosemide strongly favors obstruction
- Post-void/post-micturition images: If the collecting system empties after voiding, obstruction is unlikely
- NORA (Normalized Residual Activity): Normal < 0.5; indeterminate 0.5-1.8; obstructed > 1.8
- Differential renal function: <40% on the affected side supports surgical intervention
Important Note on DTPA vs MAG3
DTPA has a lower extraction fraction (~20%) compared to MAG3 (~40-50%), so drainage curve changes are more subtle with DTPA. MAG3 is generally preferred for obstruction evaluation, especially with reduced renal function. The T½ and percentage thresholds above apply to both agents, but DTPA results require more cautious interpretation.
Sources: Campbell-Walsh-Wein Urology; SNMMI/EANM Guideline for Diuretic Renal Scintigraphy (PMC6020824); Bailey & Love's Short Practice of Surgery 28th Ed.
In post pyeloplasty case, surgery done 8 years back, patient c/o bilateral flank pain. TAC shows a rising curve. Can this be obstructed. Post void and 2 hour delayed counts are 25k and 20k respectively. I think it is obstruction
Finding Sources
Searching the Web
post pyeloplasty rising curve diuretic renogram false positive hypotonia obstructed interpretation post void counts
Finding Sources
Searching the Web
post pyeloplasty renogram "post void" counts 2 hour delayed image obstruction versus atony interpretation
Finding Sources
Finding Sources
Finding Sources
Searching the Web
diuretic renogram post void vs 2 hour delayed counts decreasing obstruction reservoir effect interpretation post pyeloplasty
This is a nuanced case that deserves a careful, structured answer. Here is the full analysis:
Analysis: Post-Pyeloplasty Rising Curve - Is This True Obstruction?
Your Clinical Data Summary
| Parameter | Value |
|---|---|
| Surgery | Pyeloplasty, 8 years ago |
| Symptoms | Bilateral flank pain |
| TAC curve | Rising (after furosemide) |
| Post-void counts | 25,000 |
| 2-hour delayed counts | 20,000 |
The Critical Observation: Counts Are FALLING
The single most important finding here is that counts decreased from 25k (post-void) to 20k (2-hour delayed) - a drop of ~20%.
This means: the tracer is draining passively over time, even without further furosemide. This is the hallmark of a reservoir effect (atony/hypotonia of a dilated renal pelvis), NOT true mechanical obstruction.
In true obstruction, counts either plateau or continue to rise on the 2-hour delayed image. They do not fall.
Why a Rising Curve Alone Is NOT Enough to Call Obstruction Post-Pyeloplasty
Post-pyeloplasty kidneys have a well-recognized pitfall: post-surgical hypotonia/atony of the renal pelvis. Even years after successful surgery, the renal pelvis may remain dilated and floppy (patulous), showing:
- A rising or plateau TAC curve (mimicking obstruction)
- Prolonged T½ > 20 minutes
- Persistent hydronephrosis on ultrasound
This is a false-positive for obstruction. The dilated pelvis acts as a reservoir that fills faster than it drains during the dynamic phase, producing a rising curve - but given enough time, it does drain passively.
As StatPearls states: "Post-surgical hypotonia of the renal pelvis... can have T½ greater than 20 minutes but will be seen as having a lesser T½ and suggesting normalcy/no obstruction after gravity-assisted drainage (GAD)."
How to Interpret Post-Void and Delayed Counts
| Scenario | Post-void → 2hr delayed | Interpretation |
|---|---|---|
| True obstruction | Counts stable or rising | Fixed block - tracer cannot drain |
| Reservoir / atony | Counts falling (draining passively) | No mechanical obstruction |
| Your case (25k → 20k) | Falling by ~20% | Favors reservoir effect, NOT obstruction |
The SNMMI/EANM guideline explicitly states: "A renal collecting system that empties after micturition is strong evidence against obstruction." And further: "If the postvoid/max count ratio is low (e.g., 0.10), this indicates that at least 90% of activity has drained, providing strong evidence against obstruction - even if the T½ curve looked obstructed."
My Assessment: This is Likely NOT True Obstruction
Evidence against obstruction in this case:
- Counts are falling on the 2-hour delayed image (25k → 20k) - passive drainage is occurring
- Post-pyeloplasty setting - reservoir effect and pelvic atony are well-known false positives
- A rising curve in a post-pyeloplasty kidney is an expected finding due to the patulous pelvis
- True obstruction would show stable or rising counts at 2 hours
What would confirm or clarify:
- Gravity-assisted drainage (GAD): Have the patient stand upright for 5 minutes. If >50% drains, obstruction is excluded
- NORA (Normalized Residual Activity): If post-micturition NORA < 1.5, obstruction is unlikely
- Differential renal function: If preserved (>40%), less likely to be high-grade obstruction
- Cortical transit time (CTT): A normal CTT argues against obstruction even with a rising curve
Bottom Line
I would respectfully disagree with calling this obstruction. The falling counts on delayed imaging (25k → 20k) indicate passive drainage is occurring - the tracer is not "stuck." In a post-pyeloplasty kidney with known pelvic dilatation and atony, this pattern is consistent with a non-obstructed but dilated reservoir pelvis. The bilateral flank pain needs clinical correlation with other findings (stone, infection, pressure symptoms from the large pelvis), but the renogram by itself argues against a mechanical re-obstruction.
Sources: StatPearls - Nuclear Renal Scan; SNMMI/EANM Guideline for Diuretic Renal Scintigraphy (PMC6020824); A Rough Guide to the Renogram (BNMS 2018)
18F-DOPA and 68Ga-DOTA scans are suggested in which scenarios which tracer is the 1st option
Reading File
Searching the Web
18F-DOPA vs 68Ga-DOTA PET scan indications first line choice neuroendocrine tumors guidelines 2024
Finding Sources
Reading Web Page
http://www.kfnm.dk/x-documents/guidelines/201701_EANM_NEN_GL…
Finding Sources
Searching the Web
18F-DOPA first choice congenital hyperinsulinism focal medullary thyroid carcinoma paraganglioma EANM guideline
Excellent - I now have the full EANM guideline table. Here is a comprehensive, well-structured answer:
18F-DOPA vs 68Ga-DOTA PET/CT: Indications & First-Line Choice
Mechanism of Each Tracer
| Tracer | Mechanism | Targets |
|---|---|---|
| 68Ga-DOTA-SSA (DOTATATE / DOTATOC / DOTANOC) | Somatostatin receptor (SSTR) binding | Well-differentiated NETs with high SSTR expression |
| 18F-DOPA (fluorodopa) | L-DOPA uptake, decarboxylation and storage via AADC pathway | Catecholamine-producing / neuroectodermal tumors |
EANM Guideline Table: First (I), Second (II), Third (III) Choice
(Source: EANM/SNMMI Guideline for PET/CT imaging of NENs, Bozkurt et al., Eur J Nucl Med 2017)
| Tumor Type | 68Ga-DOTA-SSA | 18F-DOPA | 18F-FDG |
|---|---|---|---|
| Medullary thyroid cancer - High calcitonin | III | I | II |
| Medullary thyroid cancer - High CEA | III | II | I |
| Foregut NEN | I | Not indicated | I |
| Midgut (jejuno-ileal) NEN | I | I (co-equal) | II |
| Hindgut NEN | II | II | I |
| Pheochromocytoma - SDHD mutation | II/III | I | II |
| Pheochromocytoma - SDHB mutation | II | II | I |
| Paraganglioma - Head & neck | I | II | III |
| Paraganglioma - Abdominal/pelvic | II | I | I |
| Congenital Hyperinsulinism (CHI) | Not applicable | I (only tracer) | - |
| Neuroblastoma | II | I | II |
| Glomus tumors | II | I | - |
Summary by Scenario
18F-DOPA is the FIRST CHOICE in:
- Medullary thyroid carcinoma (MTC) with elevated serum calcitonin - superior for detecting calcitonin-secreting lesions
- Congenital Hyperinsulinism (CHI) in infants - the ONLY recommended tracer; distinguishes focal from diffuse disease, guiding surgical resection. Selectively taken up by pancreatic beta cells
- Pheochromocytoma with SDHD mutation - excellent for SDHx-related disease
- Paraganglioma - abdominal/pelvic - better than 68Ga-DOTA in this location
- Neuroblastoma - high AADC activity in this tumor
- Glomus tumors - approved indication in EU countries
- Midgut NETs - co-equal first choice with 68Ga-DOTA-SSA (note: ENETS 2024 now prefers 68Ga-DOTA-SSA alone for SI-NETs due to theranostic value)
68Ga-DOTA-SSA is the FIRST CHOICE in:
- Foregut NETs (gastric, duodenal, pancreatic, bronchial) - high SSTR2 expression
- Midgut NETs - co-equal with 18F-DOPA (but preferred when PRRT is being considered)
- Head and neck paraganglioma - high SSTR expression
- Metastatic PPGL (pheochromocytoma/paraganglioma) with suspected metastatic disease - NANETS 2024 recommends SSTR-PET as first-line for metastatic PPGL
- Unknown primary NET - whole-body staging
- Pre-PRRT assessment (mandatory - must confirm SSTR expression before 177Lu-DOTATATE therapy)
Key Decision Rules
"When PRRT (Lutetium therapy) is planned - ALWAYS use 68Ga-DOTA-SSA first, as it confirms somatostatin receptor expression and predicts response. 18F-DOPA has no theranostic role."
"When the tumor is catecholamine-secreting or AADC-pathway active (pheo, paraganglioma, MTC, neuroblastoma) - 18F-DOPA is often the preferred functional tracer, unless SDHB mutation or metastatic disease favors 68Ga-DOTA or FDG."
"For CHI in infants - 18F-DOPA is the only recommended tracer. It is superior to ASVS and all other imaging for localizing focal lesions."
Sources: EANM/SNMMI NEN PET Guideline (Bozkurt et al. 2017); ENETS 2024 SI-NET Guidance; Congenital Hyperinsulinism Clinical Practice Guidelines (PMC5537210); EANM PPGL Guideline 2019 (PMC7446938)
This is a shared conversation. Sign in to Orris to start your own chat.